Atrial Fibrillation, Postoperative

Cardiovascular
1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Helios Cardio
Helios CardioMA - Weston
1 program
1
The intervention includes Amiodarone-Infused CardiaMend patchesPhase 1/21 trial
Active Trials
NCT06730828Recruiting80Est. May 2026

Trial Timeline

Clinical trial activity over time

2024
2025
2026
Helios CardioThe intervention includes Amiodarone-Infused CardiaMend patches

Clinical Trials (1)

Total enrollment: 80 patients across 1 trials

NCT06730828Helios CardioThe intervention includes Amiodarone-Infused CardiaMend patches

Amiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery Subjects

Start: Dec 2024Est. completion: May 202680 patients
Phase 1/2Recruiting

Related Jobs in Cardiovascular

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 80 patients
1 companies competing in this space